THY1 and ovarian carcinoma: As shown in Figure 2P and Supplementary Figure 1, elevated THY1 significantly correlated with poor overall survival (OS) in glioblastoma multiforme, kidney renal papillary cell carcinoma, LUSC, mesothelioma, ovarian cancer, skin cutaneous melanoma, and uveal melanoma.